MSD Renal Cell Centre Expert Academy video transcript

[Music]

The team really pay attention to the brief, they take the time to understand

what our learning objectives are and they really work as a group to think

collectively how can they maximise the events using the knowledge of all of the

the people that are on hand and available to help us understand better.

[Music]

I know that everybody that’s been here over the last couple of days will take

that information into every single interaction that they have.

I think it’s just important for us to immerse ourselves into the customer’s

reality, so the customers being our clinicians, but also, the patients.

[Music]

It also gives us a really good opportunity to learn together as a team and to

all be on the same baseline so we know exactly what we’re dealing with.

I think I’ve started to think about kidney cancer from a very different perspective,

focusing on all the various healthcare professionals that patient may see, not necessarily

just the small area that we can focus on, on our daily basis. I think the course

has been hugely beneficial for me, in my role, because I get much more of a huge

sense now of how the multi-disciplinary team works for that patient, the number of

healthcare professionals they may see in their in their treatment journey.

Within my role I focus very much on the end stage and the systemic treatment, but

just seeing how much goes into that pathway before that systemic treatment is even

really thought about and has just been incredible. With this, it’s been, ‘can we keep

going?’, ‘can we ask more questions?’, ‘can we find out a little bit more and dig a

little bit deeper?’ because I think it’s everybody, no matter what their

background’s been, has just found it so, so beneficial.

The event has been extremely slick in the way that it’s been

organised. The preparation that the team have put into to make sure that the content

is appropriate for the audience has been incredible.

I think the way that the course has been run has been amazing, it’s been so smooth

it’s been so professional but then also really relatable, I think, to anybody

within the room, who, no matter what background they’ve come from, everything’s been

explained so, so clearly, and, yeah, it’s been a really enjoyable experience.

The main things are taking away from this course are the case workload as well as

the number of people who need to work in a team to make care as efficient as it can

be for the patient. I think I’ll take away mostly how multidisciplinary this

treatment really is. We speak, you know, been speaking to pathologists,

urologists, oncologists, clinical specialists, it’s a real sense of all these

specialties coming together. I think the MDT session we observed really brought that to life.

I think the thing that I’ll take away the most is

just the amount of teamwork that goes into all the decisions that are made

from the whole multidisciplinary team, the amount of communication that

requires, everybody is experts in their own rights but then sharing those

expertise with their colleagues has just been absolutely incremental to the effect of

patient care that has been going on. I think for me,

personally, what’s benefited me the most is I think within my role I focus very much

on the end stage and the systemic treatment but just seeing

how much goes into that pathway before that systemic treatment is even really

thought about and has just been incredible, yeah.